When added to standard treatment with hormone-based drugs, Ibrance (palbociclib ... “inform the development of our next-generation CDK inhibitors in early breast cancer,” according to Chris ...

The combination of immune checkpoint inhibitors (ICIs) with chemotherapy has revolutionized ... By encouraging innovative approaches, the topic aims to uncover new synergistic effects between ICIs and ...

State Key Laboratory of Natural Medicines, Departemnt of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China ...

It is not always successful. You must take immunosuppressant drugs after the surgery to prevent your body from rejecting the new kidney. These drugs have their own side effects, some of which can ...

Jan. 9, 2025 — A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient ...

This latest approval is the second for Tevimbra in 2024, as the drug was previously approved in the United States as a monotherapy for unresectable or metastatic esophageal squamous cell carcinoma ...

In nonsquamous NSCLC, novel agents, such as pemetrexed and bevacizumab ... patients who did not previously receive an EGF receptor inhibitor. Although the benefit of first- and second-line ...